IL312688A - Methods and compositions for treating conditions associated with central hypoventilation - Google Patents

Methods and compositions for treating conditions associated with central hypoventilation

Info

Publication number
IL312688A
IL312688A IL312688A IL31268824A IL312688A IL 312688 A IL312688 A IL 312688A IL 312688 A IL312688 A IL 312688A IL 31268824 A IL31268824 A IL 31268824A IL 312688 A IL312688 A IL 312688A
Authority
IL
Israel
Prior art keywords
preparations
treatment
methods
conditions related
central hypoventilation
Prior art date
Application number
IL312688A
Other languages
English (en)
Hebrew (he)
Inventor
Ronald Farkas
Lawrence G Miller
Luigi Taranto-Montemurro
David P White
Original Assignee
Apnimed Inc Delaware
Ronald Farkas
Lawrence G Miller
Taranto Montemurro Luigi
David P White
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apnimed Inc Delaware, Ronald Farkas, Lawrence G Miller, Taranto Montemurro Luigi, David P White filed Critical Apnimed Inc Delaware
Publication of IL312688A publication Critical patent/IL312688A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL312688A 2021-11-11 2022-11-10 Methods and compositions for treating conditions associated with central hypoventilation IL312688A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163278324P 2021-11-11 2021-11-11
US202263305305P 2022-02-01 2022-02-01
PCT/US2022/049483 WO2023086433A1 (en) 2021-11-11 2022-11-10 Methods and compositions for treating conditions associated with central hypoventilation

Publications (1)

Publication Number Publication Date
IL312688A true IL312688A (en) 2024-07-01

Family

ID=84627454

Family Applications (1)

Application Number Title Priority Date Filing Date
IL312688A IL312688A (en) 2021-11-11 2022-11-10 Methods and compositions for treating conditions associated with central hypoventilation

Country Status (9)

Country Link
US (1) US20250000823A1 (cg-RX-API-DMAC7.html)
EP (1) EP4429649A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024541315A (cg-RX-API-DMAC7.html)
KR (1) KR20240108453A (cg-RX-API-DMAC7.html)
AU (1) AU2022387440A1 (cg-RX-API-DMAC7.html)
CA (1) CA3237151A1 (cg-RX-API-DMAC7.html)
IL (1) IL312688A (cg-RX-API-DMAC7.html)
MX (1) MX2024005600A (cg-RX-API-DMAC7.html)
WO (1) WO2023086433A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025207125A1 (en) * 2024-03-26 2025-10-02 The Regents Of The University Of California Combination pharmacological interventions for obstructive sleep apnea

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
EP3685858A1 (en) * 2019-01-24 2020-07-29 Assistance Publique-Hopitaux De Paris A noradrenergic system stimulator in the treatment of central hypoventilation syndromes
US20220362221A1 (en) * 2019-11-04 2022-11-17 Apnimed, Inc. (Delaware) Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea

Also Published As

Publication number Publication date
US20250000823A1 (en) 2025-01-02
EP4429649A1 (en) 2024-09-18
WO2023086433A1 (en) 2023-05-19
MX2024005600A (es) 2024-05-21
KR20240108453A (ko) 2024-07-09
JP2024541315A (ja) 2024-11-08
CA3237151A1 (en) 2023-05-19
AU2022387440A1 (en) 2024-05-23

Similar Documents

Publication Publication Date Title
IL285269A (en) Compositions and methods for treating neurocognitive disorders
IL285270A (en) Compositions and methods for treating neurocognitive disorders
IL287456A (en) Cannabinoid compositions and methods of using
IL288909A (en) Methods of making bempedoic acid and compositions of the same
PL3858333T3 (pl) Wytwarzanie i przechowywanie liposomalnych preparatów rna odpowiednich do terapii
IL281726A (en) Manufacture of compounds and compositions for inhibiting the activity of shp2
EP4089115A4 (en) Anti-tigit antibodies and usage method
IL281082A (en) Compositions of cxcr4 inhibitors and methods of preparation and use
IL270894A (en) Human antibodies to bet v 1 and methods of use thereof
HRP20260212T1 (hr) Pripravci i postupci za liječenje mišićne distrofije
PL3761980T3 (pl) Związki aminokwasowe i sposoby zastosowania
IL272253A (en) Compositions and methods for treatment of inflammatory conditions and diseases of the skin
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
IL289970A (en) Compositions and methods for treating autoimmune disorders
EP3826667A4 (en) CLAUDIN6 ANTIBODIES AND METHODS OF TREATMENT OF CANCER
IL269158A (en) Compositions and methods for treating inflammatory diseases
IL284414A (en) Methods and compositions for the treatment of fabry disease
IL280330A (en) Compositions and related methods for agriculture
IL286492A (en) Sialidase-resistant saccharide and method of making and using the same
IL280807A (en) Oligosaccharide compositions and methods of use thereof for reducing ammonia levels
IL312121A (en) T cell manufacturing compositions and methods
IL283136A (en) Antibodies to mucin-16 and methods of use thereof
IL290891A (en) Compositions and methods of treating vascular diseases
EP4065161A4 (en) HIGH CONCENTRATION FORMULATIONS OF ANTI-CSF1 AND ANTI-CSF1R ANTIBODIES
IL289171A (en) Anti-cd53 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof